<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Lusi Chien on Medium]]></title>
        <description><![CDATA[Stories by Lusi Chien on Medium]]></description>
        <link>https://medium.com/@outlierventures?source=rss-f71d3dd194e------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*S7PdUAtmQvBkKjcSSmCXNQ.jpeg</url>
            <title>Stories by Lusi Chien on Medium</title>
            <link>https://medium.com/@outlierventures?source=rss-f71d3dd194e------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 05:41:12 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@outlierventures/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[How to hire your first salesperson]]></title>
            <link>https://medium.com/outlier-ventures/how-to-hire-your-first-salesperson-702b055ad90c?source=rss-f71d3dd194e------2</link>
            <guid isPermaLink="false">https://medium.com/p/702b055ad90c</guid>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[sales]]></category>
            <category><![CDATA[hiring]]></category>
            <category><![CDATA[growth]]></category>
            <dc:creator><![CDATA[Lusi Chien]]></dc:creator>
            <pubDate>Mon, 28 Aug 2023 17:21:42 GMT</pubDate>
            <atom:updated>2023-08-29T16:07:57.456Z</atom:updated>
            <content:encoded><![CDATA[<p>This is a re-post from The Thirteens <a href="https://outlierventureslus.wixsite.com/the-thirteens/blog">blog</a>, subscribe for start-up insights from a start-up superteam</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/925/0*Ejt_eiuWH-9zWETc.png" /></figure><p>In this interview, we will unpack some dos and don’t when you’re ready to hire your first sales person. We address questions such as:</p><p>- When is the right time to hire the sales person</p><p>- Who to look for?</p><p>- How to help them be successful</p><p><strong>Shayani</strong>: Lusi I’m excited to talk to you about all things how to make money! Can you start off by giving us a little bit about your experience and what you’ve done with different companies?<br><strong>Lusi</strong>: I have been both a founder myself, as well as founding team or early commercial team member for four different startups. In addition, I’ve been an advisor for over 20 different startups with a focus on enterprise sales, and particularly in the healthcare and life sciences field. I started in medical device (selling to physicians and healthcare systems), my more recent experience also includes life sciences, pharma and biotech. So my perspective comes from sales and go to market to larger enterprises, and more regulated industries in particular.</p><p><strong>Shayani</strong>: When you think about founder as well as the Chief Commercial Officer, I’m curious on both ends, do you see the same perspective of when one should hire the first salesperson? Is it different? Why is this role so important?<br><strong>Lusi</strong>: Bringing the right sales person on board can accelerate your startup’s trajectory, opening doors to new companies, and drive speed of adoption. However, there’s a fine line between hiring at the right time and rushing into it. Many startups make the mistake of hiring their first sales person too early, before having a well-defined sales process and target audience. So, before diving in, founders need to lay the groundwork for success.</p><p><strong>Shayani</strong>: So when do I hire the first salesperson?<br><strong>Lusi</strong>: In terms of when to bring this person on, it’s not measured by length, like six months or one year because obviously startups go through different phases. And in the healthcare industry, many products are regulated, so you actually can’t sell without sometimes an FDA clearance.</p><blockquote><em>I would say the right time is more defined by </em><strong><em>stages</em></strong><em>. The founders should be the one that’s talking to customers or potential customers. They should be the one to find what is the value and find </em><strong><em>product market fit</em></strong><em> first. We’ll have some additional blog articles about what is exactly product market fit and how do you find that, but typically, you </em><strong><em>want to be able to articulate your value in really concrete terms that matter to the business.</em></strong><em> Ideally you already have two to three pilots already going on. These might not be large contract deals from a revenue perspective, but in the field, real world experience of your product working. If you can have some testimonials or case studies, or a reference, the more that you can put in “the bag” of that salesperson, the better.</em></blockquote><p>What you don’t have for most startups is a playbook. And that’s where this first salesperson comes in. Because if you hire someone from a large company, typically they expect a playbook and a lot of resources and material. Oftentimes they are backed by a large brand. So when you are calling somebody and you say “I’m calling from Google”, everyone has heard of you. But if you’re calling somebody say, “I’m calling from startup X”, no one has heard of you. And so the way you enter is very different. It’s more about value creation value generation, a more consultative sales.</p><p><strong>Shayani</strong>: I heard some key attributes in your answer above already, but let’s unpack that more, who should you be looking for when hiring?<br><strong>Lusi</strong>: This first salesperson should be someone that comes from other startups and know how to sell a no-name brand. They know how to hustle but is also able to do this consultative sales. They know how to understand and build trust with larger companies because that’s always a question mark. Will this startup be around that I’m trusting my data, my patient’s data, my proprietary IP to?<br>Later on as this person builds a repeatable process then they should be the one to to write out your playbook, starting with extracting what’s in the founders head and the processes that the founder has already done. And adding to that different steps that really tighten the process. Whether it’s putting it into a CRM or having more of an account strategy and pre and post call prep. Those are all specific things that this person can put into place.</p><p><strong>Shayani</strong>: Do you see the value in hiring people from the same domain because they might have existing relationships or a rolodex?<br><strong>Lusi</strong>: You can find people from similar domains, but I would put caution on that statement.<br>Most industries are disrupted by outsiders. Oftentimes, the founder might be from someone from an outside domain. Perhaps you have AI experience but you don’t necessarily know understand radiology as well. So that salesperson could complement you by having that particular domain.<br>That said, be VERY careful if that takes you to a candidate from a large company. You may not be able to find such a specific match such as a start-up salesperson who have also sold a software product to radiology. However, it is helpful to find someone who have sold to say health care systems, and understand how to navigating a healthcare system, including their concerns, requirements of IT such as connecting with EPIC or a PACs system, processes, routes of entry (such as innovation arm), etc.</p><blockquote><em>The caution would be, an over emphasis on brand and people with a large rolodex in your specific field. Those people could be helpful to have on your advisory board to open doors for you.</em><strong><em> But it is absolutely a mistake to hire that person as your first full time salesperson.</em></strong><em> They can open doors but you as the founder or the founding team, really still have to close deals.</em></blockquote><p><strong>Shayani</strong>: So let’s say the founders have decided they’ve hit the milestones and have product market fit, and they’re ready to hire. Are there things they could do to prepare for this important hire?<br><strong>Lusi</strong>: The preparation shouldn’t be a separate task, this really just should be part of your daily work regardless of the hire, to set the grounds for growth.<br>The founder should be writing up <strong>deal reviews and taking meticulous notes on customer interactions:</strong></p><ul><li>how did you come about the deal?</li><li>what are the things that worked?</li><li>what values resonated?</li></ul><blockquote><em>Document, Document, Document</em></blockquote><p>I know sometimes founders start with just a scratch paper or calls, and you’re going from call to call and don’t necessarily find the time to document. Nowadays there are so many transcription services such as Otter.ai that makes this super easy, even if it’s really rough documentation, that’s better than nothing. Generative AI also has promises to help you summarize those later on if needed.</p><p><strong>Shayani</strong>: So transitioning to once this person is hired, how should you set them up for success?<br><strong>Lusi</strong>: Once you hire somebody, it’s appealing to say, “I’m done, this is a part I can let go and focus on something else.” A founder is so busy, doing product, fundraising, regulatory, company formation, hiring, etc. But that is the wrong way to transition.<br>Oftentimes there’s an an expectation that if the founder is selling X amount, and they bring in a big brand name salesperson, which typically require a quite significant upfront salary (vs. equity), that this person will be able to 5x my sales. These are unrealistic projections that typically does not come to fruition. Don’t necessarily expect a hockey stick growth if the right things aren’t in place. This person is not going to be a magic pill.<br>The founder should consider at least the first six months allowing the salesperson to shadow as much as possible. The most important thing that this new person can do is to pull all the knowledge out of your head, and they can’t do that if they’re not spending time with you. Of course, this person will bring in structure and expertise. They may open doors, (though I wouldn’t make that a necessary condition related to your previous question of do they have to be in this specific domain, they may not know 200 radiologists but they should know how to get them.)<br>It should be a co-selling process between the founder and the first salesperson for quite a bit of time. And then as this person can be more independent, the founder should still be involved in closing the deal. There is a founder magic, there’s a reason that you have the vision and passion. Your first customers are buying “you”, because you have no other track record or credibility to show.</p><p><strong>Shayani</strong>: So when can the founder get more leverage and let go?<br><strong>Lusi</strong>: In the beginning, I would say the founder should be involved in the whole thing. Then, the founder can step back from the top of the funnel, say you don’t need to do the prospecting or intro calls anymore. However, in the context of enterprise sales, you’re not selling to restaurants or small mom and pop shops, where you’re gonna have a few deals that really make or break the company and where you learn from and you’re using that brand and case study. So I would say the founders should be involved for quite a long time towards the closing.</p><p>After closing, there’s customer success. And that’s one area that startups often neglect, they they get the deal and they hunt for for the next one until the current deal becomes squeaky. This is an entire different conversation about how do you focus on customer success and doubling down and making sure that those first customers are really positive net promoters of your product.</p><p><strong>Shayani</strong>: You’re talking about bringing in this person who can start to create a playbook for future hires or even just getting more clarity into the sales process for themselves. I’m curious about the balance between being a really good athlete versus being the coach?<br><strong>Lusi</strong>: Since the context we’re talking about is enterprise sales, you’re gonna have less at bat but you need to be more strategic with each. This would be completely different if this was a consumer product or an SMB product.</p><p>This person absolutely should be able to be an athlete, you shouldn’t hire someone who then needs to immediately hire other people to do sales for you. But it should be an athlete that is thoughtful and reflective. So that even though I would say 80% of their time is not writing this playbook, they’re thinking about. “What did I learn from each customer interaction about whether or not they should be the target, their pain points, and what solutions they’re looking for?”</p><blockquote><em>This person is your eyes, ears, and feet so they should be proactive in feeding feedback from the customers back to the product teams to determine what should be built and how it’s prioritized.</em></blockquote><p>It’s someone who was capable of being both but is willing and able to do the athlete job for the majority of their time (say 80/20).</p><p>The documentation this person is doing should be a continuation of what the founder has already started. This is what also makes this person different than a later salesperson you’d hire at scale. There’s always the age old battle of sales managers getting sales people to update their CRM, and often times that’s not only for insight but an activity check. But for this person, their notes should not be checkboxes of “I emailed 3x and called 4x” but pages long in terms of, here’s what the customer wanted, here’s what they said, here’s where we failed.</p><p>Most likely you won’t have a customer success function as an early start startup. So this person will also follow that customer through deployment and implementation and continuing to get those feedback of are we actually meeting their pain points.</p><p>People from large companies don’t typically go through the full customer success lifecycle. There are some account managers for bigger accounts but they’ll manage one account, you don’t want someone like that. This first salesperson needs to be able to walk the customers through their entire journey, not just the sales process.</p><p><strong>Shayani</strong>: We talked about attributes to look for in your first sales person. How do you know that you’ve made a good hire? That may not be a outsized revenue target at least in the beginning.<br><strong>Lusi</strong>: Some things to measure include:</p><ul><li>How many at bats are you getting? How many times are you getting to talk to the customer? So the activity has to be there. It can’t just be amazing insight from one customer interaction. The activity for sure has to be there and that goes back to the athlete coach question you asked too. If this person is not willing to hustle and to work and to get you in front of people that is not a good fit. It’s not just activity such as “I made 100 calls and sent 100 emails”, it’s more how many customer interactions am I getting and what type of feedback am I getting from that and are we getting better?</li><li>Second would be progression in terms of how does your pipeline looks? So even if those things aren’t closed, is the pipeline filling up? Are you starting to get a more repeatable process? Are you able to articulate that better each time and if this person is really documenting that and sending feedback to product, you should be able to see that?</li><li>As an organization as a whole, are you getting closer to really understanding customer value and capturing some of that value? This is not just sales but also following a number of customers end to end, both the sales and the customer success.</li></ul><p><strong>Shayani</strong>: When do you know if you’re ready to hire another person? And do you see companies hiring another salesperson or a customer success person first?<br><strong>Lusi</strong>: I would hire a couple of positions before adding another sales team member.</p><p>On the sales side, you can start to fill out the top of funnel, for example in developing a BDR / SDR program where they can really generate those top of funnel for you. At this point, you should have a very clear, repeatable message. You’re not testing your message that much anymore. Of course, there’s still a startup and you’re still testing it, but it should be clear, repeatable and not changing each time. You should know who your target personas are, what they care about, and have succinct value messaging that you can target them. So hiring someone at the top of the funnel can help this person generate those at bats.</p><p>Second, on the customer success side, it depends on what deployment and implementation entails. For some of the startups I’ve been a part of, it was working with the imaging tech to review images. You could hire IT support, clinical support, etc depending on the product. But all of those should roll up with a particular account success plan and should be quarterback by the salesperson still.</p><p>From there, as you build up those functions, then that’s where you would hire your second or your third salesperson.</p><blockquote><em>One mistake that I’ve seen is hiring too many salespeople, but then not filling their times with appointment, your second and your third salesperson and will look a bit more like a traditional salesperson with a playbook. Of course, they’re still early, they still have to hunt. But typically I find that the BDRs are more cost effective to fill your funnel than a full fledged salesperson, so when you do have a salesperson you want that person’s calendar to be full of calls daily. They should be hunting themselves but you want their calendar to be full.</em></blockquote><p><strong>Shayani</strong>: We talked about this entire process from preparing to hiring to scaling. If you had a summarize, what are the top three stumbling blocks that you founders should avoid?<br><strong>Lusi</strong>: One is hiring someone with brand and glamour from large company who not thrive in a startup environment.</p><p>The second is just relegating the sales to that person once hired, instead of being staying very involved in the pipeline because you’re the founder, you have the founder magic and you have to transfer the founder magic and that doesn’t take place with two calls and in the document.</p><p>Third, is hiring too many salespeople too quickly, make it too top heavy in terms of costs. An enterprise salesperson who can do the end to end closing will always be more expensive than someone who’s doing just a portion of the work. So really building up your pipeline and making sure that when you do bring in those expensive salespeople that you have a pipeline filled, you have materials for them, and you have a playbook ready for them.</p><p><strong>Shayani</strong>: Does any of this vary by industry?<br><strong>Lusi</strong>: The majority of my experiences is in healthcare and life sciences but this for sure is applicable for this is more for larger enterprise sales where it takes a longer sales cycle. You’re looking at, maybe in the beginning over a year to close that deal on average. You can possibly bring that down to 6–9 months, and then a subsegment to 3–6 months, of course depending on your industry. It is a much more strategic sale to requires trust building and multiple levels of stakeholders. But I do think a lot of this apply across enterprise sales, for example in FinTech, when you’re talking to banks who have data and personal information, as well as a reputation and brand to uphold.</p><p><strong>Shayani</strong>: I’ve learned a lot about what to think about when hiring your first salesperson. There are a lot of other things brought up to unpack such as customer success, scaling, and onboarding successfully. Hopefully, the founders reading this can avoid making some expensive mistakes in cost or time and this really sets them up. I look forward to unpacking this more with you.</p><h3><strong>About:</strong></h3><p>Shayani and Lusi are two of the partners of your start-up superteam,<a href="https://outlierventureslus.wixsite.com/the-thirteens"> The Thirteens</a>, a start-up consultancy of fractional executives covering multiple functions and industries, super charging your start-up to the next level.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=702b055ad90c" width="1" height="1" alt=""><hr><p><a href="https://medium.com/outlier-ventures/how-to-hire-your-first-salesperson-702b055ad90c">How to hire your first salesperson</a> was originally published in <a href="https://medium.com/outlier-ventures">Outlier Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Mining Gold: Healthcare Data and It’s Potential to Unlock Patient Benefit and Create Value]]></title>
            <link>https://medium.com/outlier-ventures/mining-gold-healthcare-data-and-its-potential-to-unlock-patient-benefit-and-create-value-487fc5cd4b8c?source=rss-f71d3dd194e------2</link>
            <guid isPermaLink="false">https://medium.com/p/487fc5cd4b8c</guid>
            <category><![CDATA[data-analytics]]></category>
            <category><![CDATA[ehr]]></category>
            <category><![CDATA[medical-imaging-data]]></category>
            <category><![CDATA[real-world-data]]></category>
            <category><![CDATA[health-data]]></category>
            <dc:creator><![CDATA[Lusi Chien]]></dc:creator>
            <pubDate>Wed, 16 Jun 2021 06:32:53 GMT</pubDate>
            <atom:updated>2021-06-18T19:05:31.414Z</atom:updated>
            <content:encoded><![CDATA[<p>With the advent of big data and AI, health data can allow for the next generation of personalization of treatment, development of new drugs, and possibly prediction and prevention of chronic diseases.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/748/0*6GB5ckFJyKcxFgox.png" /></figure><p>This three part series looks at</p><ol><li>An overview of health data</li><li>How companies have used it to move from personalization to prediction to prevention</li><li>How to build a data business as a start-up</li></ol><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*CuPoEfrOE2jOQztX.jpeg" /><figcaption>Su Huang from Datavant</figcaption></figure><p>For part I, I got a chance to interview <a href="https://www.linkedin.com/in/su-huang/">Su Huang</a>, head of data strategy at <a href="https://datavant.com/">Datavant</a>. Founded in 2017, Datavant connects healthcare data to eliminate the silos of healthcare information that hold back innovative medical research and improved patient care. They help data owners manage the privacy, security, compliance and trust required to enable safe data sharing.</p><p><em>Lusi</em>: Hi Su, thanks for helping me give my readers a look into all the different types of data out there. Can you describe what are the main types of healthcare data?</p><p><em>Su</em>: “Traditional” data that has been used in healthcare research for years, these are</p><ul><li>claims data — which is the bread and butter of healthcare research</li><li>EHR data</li><li>labs data</li></ul><p><em>Lusi</em>: Let’s go into each of these, tell me first about claims data</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*O30vvVcsn0VWd3jR.jpg" /></figure><p><em>Su</em>: Claims data has been used for decades and tends to be the most longitudinal in nature since you can follow patients from provider to provider, even if they use different EHR systems. Example players in this space include: <a href="https://www.iqvia.com/">IQVIA</a>, <a href="https://www.ibm.com/products/marketscan-research-databases?p1=Search&amp;p4=43700050370609453&amp;p5=b&amp;gclid=Cj0KCQjwvYSEBhDjARIsAJMn0lihJkjggcFneuhT3F95sUT8Ooe1MayrMRsUrflyx4GWNEDNbbPbtGMaAhahEALw_wcB&amp;gclsrc=aw.ds">IBM MarketScan</a>, <a href="https://www.optum.com/business/solutions/life-sciences/real-world-data/claims-data.html">Optum Claims</a> — a division of United Health Group, and<a href="https://go.definitivehc.com/free-trial?dhc_adid=509349502932&amp;utm_term=definitive%20healthcare&amp;utm_campaign=Hospital+Affiliations&amp;utm_source=adwords&amp;utm_medium=ppc&amp;hsa_tgt=kwd-329237809646&amp;hsa_grp=118554061863&amp;hsa_src=g&amp;hsa_net=adwords&amp;hsa_mt=p&amp;hsa_ver=3&amp;hsa_ad=509349502932&amp;hsa_acc=1634535717&amp;hsa_kw=definitive%20healthcare&amp;hsa_cam=12615587253&amp;gclid=Cj0KCQjwvYSEBhDjARIsAJMn0limaHvJb63eR8mNdGgeKaix7BsK_DM-K1ZpqwxWnuo4nAO3cwZFKQkaAv9vEALw_wcB"> Definitive Health</a>care.</p><p><em>Lusi</em>: I’ve used Definitive Healthcare for several of my start-ups, but it seems that the bulk of its offerings are Medicare data which tend to be a couple of years old. I know they’ve started to introduce commercial data recently as well. What are the limitations of the current state of data?</p><p><em>Su</em><strong>:</strong> Some of the differences to keep in mind come from how these companies source the underlying claims data that they have. There are two broad distinctions in claims databases — some databases such as those provided by IQVIA and Symphony Health aggregate data from many different claims clearinghouses and provider billing systems. These large data aggregators will cover more patient lives, but may not have 100% claims capture for each patient. Other databases such as those provided by IBM MarketScan, Optum, Blue Health Intelligence, and Inovalon Insights, have claims data from health plans or self-insured employer groups. The claims databases offered by these companies tend to cover fewer patient lives, but will have 100% claims capture for each patient. It’s important to understand that all these providers de-identify the data first, stripping away identifiers (e.g. name, date of birth, phone number, address, etc) so that patient privacy is not compromised but the value of the health data is retained for analytic purposes.</p><p>Other factors to keep in mind as you evaluate claims data providers are data latency, granularity of data fields, permitted use cases and pricing.</p><p><em>Lusi</em>: How about EHR data, does it address some of these concerns?</p><p><em>Su</em><strong>: </strong>EHR data is less longitudinal than claims data, but you can obtain greater detail on a patient’s condition, symptoms, and disease progression by using EHR data. The challenge with EHR data is that as much as 80% of the data could be in physician notes which sit in unstructured data fields. Thus, curating EHR data first will maximize the utility of the EHR record. Companies like <a href="https://flatiron.com/">Flatiron</a>, <a href="https://www.ontada.com/">Ontada</a>, and <a href="https://www.concertai.com/">ConcertAI </a>do this with oncology EHR data. <a href="https://www.cerner.com/solutions/real-world-data">Cerner</a>, one of the largest EHR providers for hospitals, is starting to develop real-world data offerings for researchers. Start-ups like<a href="https://omnyhealth.com/"> OMNY Health</a> are creating platforms for hospitals to be able to commercialize their data and make it available for analytics.</p><p><em>Lusi</em>: What are ways start-ups can add value to EHR data since it is so largely unstructured?</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/974/0*0am9xQiQUm7HcHhA.png" /></figure><p><em>Su</em>: There is a lot of opportunity to apply natural language processing and machine learning techniques to EHR data. Many of these aforementioned companies still rely on a process called clinical abstraction, which means deploying teams of people with clinical backgrounds to curate data from unstructured fields into structured fields. It is a heavily manual process today. Startups can apply data scientists and engineers to solving this big problem and making it more seamless to organize and use unstructured health data. Startups like <a href="https://www.mendel.ai/">Mendel.ai</a> are focused on solving this problem of automating the translation of unstructured into structured, analytics-ready data, as are big companies like Amazon, through their <a href="https://aws.amazon.com/healthlake/">HealthLake</a> product.</p><p><em>Lusi</em>: Finally, let’s talk about labs</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/590/0*NovsYecJdNeqMaP4" /></figure><p><em>Su</em>: Approximately<strong> 70% of diseases are diagnosed through lab testing</strong>, making it a vital part of understanding a patient’s journey. Therapeutics are also becoming increasingly biomarker driven, which makes lab data, especially genomic lab data, a key part of selecting the right treatment for a patient. You can obtain lab data from analytic platform companies like <a href="https://prognoshealth.com/prognosfactor/marketplace/">Prognos Health</a>, which aggregates and normalizes data from many different labs. Or, you can work with individual labs themselves who may have teams focused on licensing de-identified data or conducting analytic projects on their data.</p><p><em>Lusi</em>: I know <a href="https://www.tempus.com/">Tempus </a>started out as a lab service but has really hit it out of the park with a $1B+ valuation. There are also various new entrants looking for easier ways to test at home such as <a href="https://nephrosant.com/">Nephrosant</a> with urine-based tests and <a href="https://qvin.com/">Qvin </a>using menstrual blood.</p><p><em>Lusi</em>: You mentioned traditional sources of data, what are some emerging ones?</p><p><em>Su</em>: There are so many other sources of healthcare data, such as genomics data, remote monitoring device data, fitness tracking data, telehealth data, disease-specific registries, and imaging data. There’s also a broad category of data called Social Determinants of Health data (SDoH) which are conditions in which people live, learn, work, and play (e.g. where you live, your education level, your access to transportation, etc) that health researchers are increasingly interested in because they impact health outcomes. All of these data types are broadly referred to as Real World Data (RWD) which is defined as any data that relates to a patient’s health and delivery of care that is routinely collected in a person’s regular life (and outside of the clinical trial setting).</p><p><em>Lusi</em><strong>:</strong> It’s interesting that you mention imaging data. Having just come from the imaging space, I am aware of several players who have a lot of imaging data, but it seems like the primary use case for the data is to train AI algorithms for disease detection, and not leveraged as much beyond that.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/0*sRpZTT_Ff3Cce4ol.png" /></figure><p>Some existing imaging data players include:</p><ul><li>American College of Radiology</li><li>PACs vendors such as Change Healthcare or LifeImage</li><li>Start-ups such as Segmed</li><li>Hospitals and Image Centers such as Stanford, Partners Health, Radnet, and RadPartners</li><li>AI in Medical Imaging players such as AIDOC, Subtle Medical, Clarify and Zebra, though they’re not so much commercially sharing the data itself vs using it for their own research</li></ul><p><em>Su</em><strong>:</strong> There is definitely interest in imaging data, but typically, RWD needs to be de-identified first (unless you have patient consent to use their identified data for research) and ideally turned into structured data. So, I think that is one of the challenges to broader adoption of imaging data in RWD research. Additionally, as with other complex types of big data such as genomics, there can be challenges to finding the right people with clinical expertise to process and interpret this kind of data. Lastly, there are technical challenges to storing, querying and analyzing imaging data for RWD use cases.</p><p><em>Lusi</em>: It seems that previously data had been used more for sales and marketing (e.g. determining market share, market size, etc) but now it’s moving more towards influencing personalized treatment and even future drug discovery?</p><p><em>Su</em><strong>:</strong> Data for commercial use cases is still a large area of spend for pharmaceutical companies. However, use of RWD in the clinical trial space is accelerating especially in areas like oncology where the populations that need to be recruited for clinical trials is becoming increasingly precise, and there are more long-term follow up requirements. The FDA’s 21st Century Cures Act, enacted in 2016, helped accelerate the acceptance of using RWD to modernize clinical trial design and speed up the clinical development process. A very tangible way in which RWD is accelerating trials is by enabling synthetic control arms (SCAs) — this means that instead of recruiting patients for a traditional control arm, you design the control arm by using the real-world health records about a cohort of patients. This reduces recruitment time and overall cost of a trial. BCG has a great article about SCAs <a href="https://www.bcg.com/publications/2021/synthetic-control-arms-changing-clinical-trials">here</a>.</p><p><em>Lusi</em>: It is clear that one source of data is no longer sufficient, and the “smartest” solutions are combining EHR, imaging, genomics and labs data all together. Who are effectively using multi-model data and what remain the challenges of stitching everything together?</p><p><em>Su</em><strong>: </strong>Yes, that is the smart approach given the wealth of data we have today. Enabling data to be stitched together while maintaining patient privacy is what <a href="https://datavant.com/">Datavant’s </a>technology offers. There are many companies that are doing this effectively from big pharma manufacturers like Janssen to analytic companies like Komodo Health, TriNetX, or IPM.ai. There has been a particular explosion of healthcare analytic companies that are applying advanced analytic techniques to massive amounts of aggregated data. Many start off with one or two specific focus areas and then expand into other use cases for their platform. For instance, Komodo Health has built a real-time Healthcare Map to help with patient journey understanding. TriNetX has a platform to help sponsors with clinical trial site selection and recruitment. IPM.ai can build models on aggregated data that help rare disease patients achieve earlier diagnoses. These are many others as well.</p><p>Thanks so much for sharing this overview with me today and there definitely seems to be a lot going on in the healthcare data space. We will talk in Part II about how all of this data is making a difference in patient lives by moving treatment from personalization to prediction to prevention.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=487fc5cd4b8c" width="1" height="1" alt=""><hr><p><a href="https://medium.com/outlier-ventures/mining-gold-healthcare-data-and-its-potential-to-unlock-patient-benefit-and-create-value-487fc5cd4b8c">Mining Gold: Healthcare Data and It’s Potential to Unlock Patient Benefit and Create Value</a> was originally published in <a href="https://medium.com/outlier-ventures">Outlier Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Why and How to Take a Sabbatical]]></title>
            <link>https://outlierventures.medium.com/why-and-how-to-take-a-sabbatical-14291c0a20fe?source=rss-f71d3dd194e------2</link>
            <guid isPermaLink="false">https://medium.com/p/14291c0a20fe</guid>
            <category><![CDATA[planning]]></category>
            <category><![CDATA[sabbatical]]></category>
            <dc:creator><![CDATA[Lusi Chien]]></dc:creator>
            <pubDate>Fri, 28 May 2021 22:21:18 GMT</pubDate>
            <atom:updated>2021-06-16T06:09:16.942Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*co4jxW50IShAys3I.jpg" /><figcaption>Gazing at the Sunset at the Grand Canyon on My Sabbatical</figcaption></figure><p>For those who have the financial means to do so, I highly recommend taking a sabbatical every few years to ensure you’re aligned with your goals, see the big picture, and refresh to get ready for your next challenge.</p><p>I love early stage start-ups, but they can also be all consuming as it’s like raising a baby each time. You get to know every aspect of the business from the ground up. You feel like you can’t get away as things really depend on you. You’re tapping into every aspect of your energy and brainpower, often mulling over things even after the workday is “done.” You’re emotionally tied into the roller coaster of successes and pitfalls.</p><p>That is why after my past two start-ups, I’ve deliberately chosen to taken a sabbatical. Each time I’ve re-emerged more sure, energize, and invigorated to jump into my next challenge.</p><h4>Why take a sabbatical?</h4><p>Before taking a sabbatical, understand your goals for it. For some, it is to do something different, like train to be a yoga teacher or to write a book. For me, it is to gain a fresh perspective on the market and to have some more “sit on the bench and think time.” I wanted to figure out where I should invest my time into next, where the market was going, what are some trends in the industry.</p><p>It is also often, of course, to relax, spend time with family, take vacation, and recharge.</p><h4>Is it risky?</h4><p>It can seem daunting to be “without a job.” True, there is a bit of a question from recruiters when you’re not working, but this can be mitigated in various ways:</p><ul><li>Take up active consulting roles and talk about what you’re doing, this is also a great way to find your next opportunity</li><li>Be active in thought leadership / writing, the quality of your content should attract those who are looking for your specific talent</li><li>Have strong references from your previous roles</li><li>Consider taking a sabbatical within the same company</li><li>Devise a plan for what to do so you won’t be too busy being worried</li></ul><h4><strong>A sample way to plan for your sabbatical</strong></h4><p>I received this list from a friend who worked with a coach while planning her sabbatical, and received permission to share it as it was extremely helpful for me</p><p>1) Visioning</p><p>Made a visioning board of what an amazing sabbatical would look like. Literally cutting out things from magazines, writing down words that came to mind etc. or do this on Pinterest</p><p>2) Laundry list</p><p>Write down a list of things you want to do, feel free to let this be super random — from some books to read to watching a movie on a Tuesday morning in bed while eating chocolate :-)</p><p>3) Some formal training / class</p><p>Perhaps a yoga-teacher training class? coding class? art history class? Goal is to get a different part of the brain going and learning.</p><p>4) Digital detox -</p><p>X weeks without opening laptop, be more present and creative with those around you, works especially well in spending time with kids</p><p>5) Personal training / fitness</p><p>6) Assessments (as a way to collect data — look at all those assessments at once; here’s a sampling some of those tests, and they do change over time)</p><p><em>Strengthfinders:</em></p><p><a href="https://store.gallup.com/p/en-us/10003/cliftonstrengths-34">https://store.gallup.com/p/en-us/10003/cliftonstrengths-34</a></p><p><em>Myers Briggs</em></p><p><a href="https://www.mbtionline.com/en-US/For-you">https://www.mbtionline.com/en-US/For-you</a></p><p><em>Michael Hyatt Lifescore</em></p><p><a href="https://assessments.michaelhyatt.com/lifescore/">https://assessments.michaelhyatt.com/lifescore/</a></p><p><em>Kolbe</em></p><p><a href="https://www.kolbe.com/kolbe-a-index">https://www.kolbe.com/kolbe-a-index</a></p><p><em>Highland Assessment Battery — quite expensive but really cool. 3 hours in depth online tests and then having a psychologist (phd) play back to you what that means for ideal work, life environment.</em></p><p><a href="https://www.highlandsco.com/get-started/">https://www.highlandsco.com/get-started/</a></p><p>7) Go back to people you haven’t worked with for a while and ask them what they remember the most helpful thing you did was and the least helpful [with benefit of hindsight and some distance]</p><p><a href="https://www.landit.com/">Landit </a>is a great tool for doing this if you want to put some tech behind it</p><p>8) Lastly: Making sure you have time every week without any plan.</p><h4>Getting back to work</h4><p>For friends of mine, they wanted time to be fully off before starting to look for a job, and then once they were ready, they went into full time job search mode. For me, I found advising and consulting for early stage companies in the spaces I was interested in was a great way to “expand my mind” while having a lighter load. It could also possibly turn into my next role, without the pressure of needing to find my next job when you’re engaging with people. For many start-ups, it’s also a great way to really feel the fit of a potential senior candidate into the culture and how much value they can bring. This is a bit easier if you’re looking into early stage companies, as many large companies can be more rigid.</p><p>Your timeline will depend on your goals and also your budget. I had a longer timeline than I actually took, but was open to jumping back early to a full time opportunity if I found the right fit. This allowed me to really look for something I wanted to invest in for the next season of my life, rather than being compelled to “find a job.”</p><p>During my first sabbatical in 2016, I spent time consulting for various companies in the AI space, and got to understand it’s many winters and summers. One of the companies I worked with (or really the two co-founders) was <a href="https://subtlemedical.com/">Subtle Medical</a>, a start-up using AI applied to medical imaging, which I ultimately joined and led the commercial team up to its recent Series A.</p><p>During my recent sabbatical in 2021, I initially took a step back to look at overall trends in healthcare: data, precision medicine, real world evidence, chronic disease management, early detection, and remote care. I got a chance to advise various start-ups through <a href="https://www.astia.org/">Astia</a>,<a href="https://rosenmaninstitute.org/"> USCF Rosenman Institute</a>, and my network. I took two meetings a week on <a href="https://lunchclub.com/home">Lunchclub</a>, and lurked on various sessions on Clubhouse. I re-connected with friends. I wrote. I figured out what “skills” I was good at— which I initially found hard to articulate since it was something I did everyday, so advising start-ups helped me figure out what questions I was answering repeatedly. Our family traveled during the window post vaccination and before travel became crazy, visiting the Big Island of Hawaii, Scottsdale / Sedona / Grand Canyon, and Yosemite.</p><p>I am excited to announce the end of my sabbatical to join <a href="https://medium.com/u/716c86f3f946">Nanome</a>, a VR platform for the next generation of science, starting with drug discovery. I am energized by the young team of passionate founders. Like with AI four years ago, I am bullish at the inflection point of VR/AR and mixed reality as the future of work and collaboration, though admittedly it’s a bit earlier in the trajectory, but clearly out of the woods with all the major tech players: FB, Apple, HTC, Microsoft, Sony, Lenovo, NVIDIA, and others investing in the next generation hardware.</p><p>I hope you’ll have a chance to take a sabbatical yourself, and I am excited to share more about <a href="https://medium.com/u/716c86f3f946">Nanome</a> with you in the future.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=14291c0a20fe" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Show Me the Money: How To Get Paid In Healthcare (Part 4 Bonus!)]]></title>
            <link>https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-4-bonus-3a0e4c898f63?source=rss-f71d3dd194e------2</link>
            <guid isPermaLink="false">https://medium.com/p/3a0e4c898f63</guid>
            <category><![CDATA[medical-devices]]></category>
            <category><![CDATA[sales]]></category>
            <category><![CDATA[partnerships]]></category>
            <category><![CDATA[healthcare-innovations]]></category>
            <dc:creator><![CDATA[Lusi Chien]]></dc:creator>
            <pubDate>Mon, 22 Mar 2021 17:03:23 GMT</pubDate>
            <atom:updated>2021-03-22T17:38:26.800Z</atom:updated>
            <content:encoded><![CDATA[<h4>Healthcare is one of the only industries where the consumer of the product / service is usually not the one who pays for it. Understanding who pays for healthcare is important in bringing innovation to the space that’s lasting.</h4><p>This is a series that aims to help start-ups, in particular those with tech founders who are entering healthcare for the first time, get up to speed on the basics of healthcare commercialization.</p><p>To review, healthcare services and medical devices are sold to three major categories:</p><ol><li><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-1-805d66fb004f">B2C: the consumer (the smallest)</a></li><li><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-2-providers-4c08e5f0e047">B2B: the provider</a></li><li><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-3-payer-8668f5fbb6e1">B2B: the payer</a></li></ol><p>So what’s part 4? Today I will describe business models that sell to medical device companies. Ultimately this is really a corollary to the above 3 to enable said distribution / channel / product partner to sell their products better and gain more market share</p><p>Let’s dig into this last segment</p><h3>The “4th” Buyer: Medical Device</h3><p>This is not a market segment by itself as it’s really a channel ultimately to providers or payers, but start-ups can create significant value either directly or using these as channels to get to market.</p><p><strong>What they care about</strong>: increasing revenues on existing products and getting new products to market better, safer, faster, and cheaper</p><ul><li>Medical device companies may partner with start-ups that can help them increase their market share by either identifying more eligible patients, better targeting of patients, or providing a better integrated solution to those patients.</li></ul><p><strong>Examples:</strong></p><ul><li>Some of the largest companies in the world have targeted healthcare and life sciences as a segment to achieve their goals, such as <a href="https://www.salesforce.com/solutions/industries/healthcare/customer-stories/#!page=1">Salesforce</a>, <a href="https://aws.amazon.com/health/case-studies/?case-studies-health-cards.sort-by=item.additionalFields.publishedDate&amp;case-studies-health-cards.sort-order=desc">AWS</a>, and Apple (see this example of MyMobility launched by <a href="https://www.zimmerbiomet.com/medical-professionals/zb-connect/mymobility.html">Zimmer</a>)</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/0*cqLUuxRx_EPw_QZu.png" /></figure><ul><li>Start-ups can do the same by providing solutions that help hospitals understand which patients would most benefit from the medical device company’s solutions, or help with post surgical recovery for example.</li></ul><p><strong>Limitations: </strong>While start-ups can scale with partnerships, cementing these partnerships can take 12–18 months. For any deals that are distribution centered, where the company is a channel to the end customer, scale is not guaranteed as you still need to convince the sales team to keep you top of mind amongst their bag of many products, and ultimately the provider needs to have a great experience managed through a third party.</p><ul><li>It is important as a start-up to not be “crushed” by these large deals, which sound like a great opportunity but requires significant scale-up ahead of revenue. It can also remove the start-up from the end customer, where in the early days the customer obsession is hugely important to obtain feedback and iterate quickly to get product market fit.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/300/0*vapjQAKRtQANO4xH.jpg" /></figure><ul><li>I’ve heard a large device company say that they don’t mean to “crush” their partners, but like an elephant playing with an ant, sometimes it happens despite the best intentions on both sides. This is especially true if the start-up has to scale up costs for operations or support in order to meet the demands of its partner. What might be a quick decision making process could be ages in a start-up’s time table, and a decision by a large company to delay a potential project by quarters could be a death blow to their start-up partners if they were counting on that revenue.</li><li>Ways to mitigate this include</li></ul><ol><li>Have multiple sources of revenue and traction and not being tied to one exclusive partner</li><li>Be close to the end customer yourself especially in the beginning, expect to do 90% of the sales and for the first few deals to not be scalable in terms of sales and support effort</li><li>Discuss product and ramp of product or support services with commitments from the partner, so you’re not incurring risky costs alone</li><li>Ramp up the partnership slowly, select one region or group of customers where you can mutually show success first</li><li>Dive deep into the sales compensation and structure of the larger company, to ensure you’ll be on the top of their “bag”</li></ol><p><strong>Opportunity: </strong>While start-ups should tread carefully, the opportunity is of course scale and the backing of a significant brand. Oftentimes these may also come with investments, examples being the <a href="http://isrg.intuitive.com/news-releases/news-release-details/intuitive-launches-100-million-venture-capital-fund">Intuitive Surgical fund</a> or <a href="https://www.crunchbase.com/hub/medtronic-portfolio-companies">Medtronic Ventures</a>. In fact, according to <a href="https://www.cbinsights.com/research/medical-device-companies-healthcare-investments/">CB Insights</a>, 16 of the world’s 20 largest medical device companies have invested in at least 1 healthcare startup since 2016.</p><h3>Pharma Addendum</h3><p>In the beginning I said I specifically left pharma off for this article, but I would be remiss not to mention the huge trend in data that is fueled by pharma as an end customer (examples include <a href="https://www.tempus.com/">Tempus</a>, <a href="https://flatiron.com/">Flatiron Health</a> — acquired by Roche, etc.) However, “get enough data until I’m big enough to sell to pharma” is not a 101 strategy, but rather a level up growth that can be designed and engineered for the future. Ultimately, start-ups need to execute the first level value and service well — to one of the three segments above, in order to get to a place of having enough data to matter</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/0*FEwTxMuT82p9F5tP.jpg" /></figure><p>I’d be interested to hear from you different examples of companies that have been successful in each of these categories, or perhaps ones that broke the mode and charted a new path.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3a0e4c898f63" width="1" height="1" alt=""><hr><p><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-4-bonus-3a0e4c898f63">Show Me the Money: How To Get Paid In Healthcare (Part 4 Bonus!)</a> was originally published in <a href="https://medium.com/outlier-ventures">Outlier Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Show Me the Money: How To Get Paid In Healthcare (Part 3 — Payer)]]></title>
            <link>https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-3-payer-8668f5fbb6e1?source=rss-f71d3dd194e------2</link>
            <guid isPermaLink="false">https://medium.com/p/8668f5fbb6e1</guid>
            <category><![CDATA[chronic-disease]]></category>
            <category><![CDATA[healthcare-nt-sickcare]]></category>
            <category><![CDATA[self-insured-plans]]></category>
            <category><![CDATA[insurance]]></category>
            <category><![CDATA[healthcare]]></category>
            <dc:creator><![CDATA[Lusi Chien]]></dc:creator>
            <pubDate>Fri, 19 Mar 2021 15:52:26 GMT</pubDate>
            <atom:updated>2021-03-22T17:39:48.689Z</atom:updated>
            <content:encoded><![CDATA[<h3>Show Me the Money: How To Get Paid In Healthcare (Part 3 — Payer)</h3><h4>Healthcare is one of the only industries where the consumer of the product / service is usually not the one who pays for it. Understanding who pays for healthcare is important in bringing innovation to the space that’s lasting.</h4><p>This is a series that aims to help start-ups, in particular those with tech founders who are entering healthcare for the first time, get up to speed on the basics of healthcare commercialization.</p><p>To review, healthcare services and medical devices are sold to three major categories:</p><ol><li><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-1-805d66fb004f">B2C: the consumer (the smallest)</a></li><li><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-2-providers-4c08e5f0e047">B2B: the provider</a></li><li>B2B: the payer</li></ol><p>This is part 3, where I’ll deep dive into payers, and where exciting work is being done outside of “sick care” into “health” care.</p><h3>B2B: The Payer</h3><p><strong>What they care about</strong>: payers want to manage the population they serve by lowering the overall cost of care</p><ul><li>Payers are a great place for <strong>chronic disease management</strong> that are not so “episodic”, and where recent push in healthcare to provide “health” rather than just “sick care” have gained more traction.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/456/0*ofJK_Cfv5chdnhUf" /></figure><ul><li>New technologies can gain reimbursement and coverage from payers by showing better efficacy and lower overall cost, though they are still paid through the providers in this case</li><li>Several programs target payers directly by helping them manage a population (e.g. diabetics) whereby preventing, delaying, or managing the chronic condition over a long period of time allows payers to save money</li></ul><p><strong>Types of Payers:</strong></p><ul><li>You’ve probably heard of the large insurance companies like Blue Cross Blue Shield, Anthem, Cigna, etc. though sometimes they hold the risk while other times they’re simply the interface to administer the insurance program (e.g. new companies such as <a href="https://collectivehealth.com/">Collective Health</a>)</li><li>Many large companies (think Walmart, Amazon, Lowes, Home Depot) choose to self-insure, (61% of covered employees according to Kaiser Family Foundation), meaning they take on the cost of the care for their employees and dependents</li><li>There’s been many new companies in the insurance space itself as well such as <a href="https://www.hioscar.com/">Oscar</a> and just launching <a href="https://www.anglehealth.com/">Anglehealth</a> that bring a new tech angle to this existing business, by adding tech enabled tools, preventative services, and revamping the whole patient experience</li></ul><p><strong>Example companies:</strong></p><ul><li>Chronic disease management companies love to target self-insured employers, such as <a href="https://www.omadahealth.com/">Omada</a>, <a href="https://www.virtahealth.com/">Virta</a>, <a href="https://onduo.com/">Onduo</a>, <a href="https://www.livongo.com/">Livongo </a>(now Teledoc), and <a href="https://www.hingehealth.com/">Hinge</a></li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/649/0*ghVCtidOBBpQa1cw.png" /></figure><ul><li>This started in diabetes but nowadays you think of a chronic disease and there’s likely a company (or five) trying to tackle it: heart failure, diabetes, mental health, gut health, hypertension, sleep apnea, etc.</li><li>Others such as <a href="https://www.carrumhealth.com/">Carrum Health</a> try to help them arbitrage differential cost of care but don’t provide the care directly</li><li>With COVID, telehealth and care at home have been on the rise, targeting both providers with tools to enable them to do telehealth (e.g. <a href="https://myiahealth.com/">Myia health</a>) but also going directly to payers. In fact, <a href="https://amazon.care/">Amazon Care</a> just launched with its own version of telehealth first serving it’s own employees.</li></ul><p><strong>Limitations: </strong>Self-insured employers as well as Medicare Advantage plans seem to be the best place to start for many of these companies. Since many programs target chronic diseases, it can take quite a long time to establish efficacy.</p><p>Once “sold” to an employer, it’s just a foot in the door to also obtain employee engagement to use the services, so it’s both B2B and B2B2C sales. Given patient privacy issues, employers cannot get into specific identification of who should actually enroll in certain programs so programs need to get the attention of individuals to engage and adhere</p><p><strong>Opportunity: </strong>Much of healthcare is long term and not episodic, and given the way healthcare is paid for in the US, which is mostly by payers and not consumers, this is where large scale population based impact on health and wellness can really make a dent before it is too late</p><p>Stay tuned Monday for the <a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-4-bonus-3a0e4c898f63">final part 4 bonus: medical device channels</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8668f5fbb6e1" width="1" height="1" alt=""><hr><p><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-3-payer-8668f5fbb6e1">Show Me the Money: How To Get Paid In Healthcare (Part 3 — Payer)</a> was originally published in <a href="https://medium.com/outlier-ventures">Outlier Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Show Me the Money: How To Get Paid In Healthcare (Part 2 — Providers)]]></title>
            <link>https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-2-providers-4c08e5f0e047?source=rss-f71d3dd194e------2</link>
            <guid isPermaLink="false">https://medium.com/p/4c08e5f0e047</guid>
            <category><![CDATA[sales]]></category>
            <category><![CDATA[healthcare-provider]]></category>
            <category><![CDATA[healthcare-innovations]]></category>
            <category><![CDATA[healthcare]]></category>
            <dc:creator><![CDATA[Lusi Chien]]></dc:creator>
            <pubDate>Thu, 18 Mar 2021 12:42:40 GMT</pubDate>
            <atom:updated>2021-03-20T01:05:52.796Z</atom:updated>
            <content:encoded><![CDATA[<h3>Show Me the Money: How To Get Paid In Healthcare (Part 2 — Providers)</h3><h3>Healthcare is one of the only industries where the consumer of the product / service is usually not the one who pays for it. Understanding who pays for healthcare is important in bringing innovation to the space that’s lasting.</h3><p>This is a series that aims to help start-ups, in particular those with tech founders who are entering healthcare for the first time, get up to speed on the basics of healthcare commercialization.</p><p>To review, healthcare services and medical devices are sold to three major categories:</p><ol><li><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-1-805d66fb004f">B2C: the consumer (the smallest)</a></li><li>B2B: the provider</li><li><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-3-payer-8668f5fbb6e1">B2B: the payer</a></li></ol><p>There are also business models that sell to medical device companies, but ultimately this is really a corollary to the above 3 to enable them to sell their products better and gain more market share</p><p>This is part 2, where I’ll deep dive into providers. This is the bulk of where innovations are sold to and delivered to patients, and where I personally have the most expertise</p><h3>B2B: The Provider</h3><p><strong>What they care about</strong>: providers want to provide the best care for patients, but they are also balancing a business (even if non-profit) of revenue (reimbursements) from payers vs. the cost of care.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/600/0*rKn59gJStLS2b__K.png" /></figure><ul><li>Previously in a full fee for service space, attracting more services meant more revenue, as such they looked for new technologies and services that attracted patients. However, this model has not always been the best for the patients and caused a ballooning of our healthcare costs.</li><li>More and more so the US is shifting towards value based care — where the providers are paid a set amount for a certain episode of care (e.g. knee replacement), including all labs, imaging, surgical, and recovery, as well as re-admissions costs related to the episode. With this, providers care about providing the best care for the lowest cost by decreasing complications and making sure the job is done right the first time, without excessive services that may not be marginally beneficial. In this world, providers are interested in technology to can provide benefit for the lowest cost (e.g. virtual care vs. in office visit, minimally invasive surgery over open surgery, and software / tools that allow for better patient management). Providers get paid by attracting the right patients for the profile they can manage</li></ul><p><strong>Types of Providers:</strong></p><ul><li>Large hospital networks such as HCA, Providence, including accountable care organizations like Kaiser and Geisinger that provide both the insurance and the care</li><li>University hospitals and specialty centers such as Stanford, UCSF, Memorial Sloan Kettering</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*eFoXsRrU9NjlJCuQ" /></figure><ul><li>Community hospitals (though they are gradually getting consolidated into IDNs)</li><li>Specialty centers for particular services in various sizes, such as imaging (Radnet, RadPartners), surgery (Ambulatory Surgical Centers, Rothman for Orthopedic), labs (Labcorp, Quest), etc, some of which are for-profit and private equity owned, and can be a quicker entryway relative to the hospitals</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*V9n4Em-NzOgzrcCT.jpg" /></figure><ul><li>Often times the sale here doesn’t end to the facility (e.g. any type of procedure or lab related reimbursement) but rather at the provider level to choose your device over your competitor’s — this is why field reps and field marketing are very important in many of these sales to drive procedure volume</li></ul><p><strong>Most healthcare companies sell to this segment so there are too many to list, but some categories include:</strong></p><ul><li>Surgical technologies such as <a href="https://www.intuitive.com/en-us">Intuitive Surgical</a>, <a href="https://tenexhealth.com/">Tenex Health</a> (another former employer), Stryker, Medtronic, J&amp;J, etc; these are typically procedure based so the sale in not just one time but rather on-going with the providers who may have a choice of what’s used on every case</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*DoYzEBVWo3Yj0dHy.jpg" /></figure><ul><li>Diagnostic hardware and software, from GE, Siemens, Philips, <a href="https://www.butterflynetwork.com/">Butterfly Networks</a> and <a href="https://captionhealth.com/">Caption Health</a> for ultrasound, <a href="https://www.heartflow.com/">Heartflow</a> for heart disease, to my former employer: <a href="https://subtlemedical.com/">Subtle Medical</a>, which sold a Saas software subscription in the medical imaging world</li><li>Lab based diagnostics such as <a href="https://www.kariusdx.com/">Karius </a>and <a href="https://www.natera.com/">Natera</a>; these, similar to surgical procedures, will be based on volume so is on on-going sale to ensure providers are prescribing them to the appropriate patients</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*LZxCa_8dTrIP84yq.jpg" /><figcaption>Compliments of Heartflow — FFRCT demo</figcaption></figure><ul><li>Enterprise software that are either sold to IT or heavily involve them, such as EHR systems (EPIC), PACs companies (<a href="https://sectra.com/">Sectra</a>, <a href="https://www.intelerad.com/en/">Intelerad</a>, <a href="https://www.changehealthcare.com/">Change</a>, etc), and the recent trend of telehealth providers and a variety of other companies enabling greater <strong>care at home</strong></li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*_T17t98XcyhJKOGuKPqw_g.png" /><figcaption>Analysis compliments of Daniel van den Bergh at Kaiser Ventures</figcaption></figure><ul><li>In recent years, software vendors that use AI / data analytics to help providers operate with better results, communicate better, and provide better care (e.g. <a href="https://www.kelahealth.com/">Kela Health</a>, <a href="https://qventus.com/">Qventus</a>, <a href="https://collectivemedical.com/">Collective Medical</a>, etc)</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/930/0*fDCmj5jpNM1VBe-U.jpg" /><figcaption>Qventus Dashboard for Hospital Optimization</figcaption></figure><p><strong>Limitations: </strong>Hospital sales can take time, large chains and academic centers can take from 12–18 months, while even a community hospital will take 6–9 months. While experience, rolodex, and having case studies can <a href="https://medium.com/outlier-ventures/sales-deck-2-0-shorten-your-b2b-sale-cycle-by-months-525d21959b69">shorten this</a> as much as possible, start-ups need to go into this space with eyes wide open and plan their revenue cycle accordingly.</p><p>Part of the reason why selling to providers take so long is that it’s often a multi-stakeholder sale. You have to prove your solution clinically (unless you stay purely in the back office), establish ROI so they pay for it from their operational budget or have reimbursement (which by itself can take 4–5 years to get adequate coverage after getting a code), and convince IT to share with you patient data (the more data and deep EHR integration, the longer the sale and deployment cycle).</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/724/0*Xe7gg-bvV1CjaFA6.jpg" /></figure><p><strong>Opportunity: </strong>While it can take a long time, this is really one of the main drivers of healthcare adoption that’s closest to the patient, and pretty much a must-have for many new technologies. <a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-1-805d66fb004f">B2C solutions</a> that involve remote patient monitoring or virtual care can significantly scale if adopted by a large provider network that will then introduce it to their patient base. Once you get a few reference accounts and pave the way towards reimbursement, you can create a significant moat against new entrants. Furthermore, there are ways to shortcut this if you can leverage some of the specialty centers that tend to focus more on operations, or GPO relationships to gain scale.</p><p>There are too many companies to list, but have I missed any general categories that are sold to providers?</p><p>Stay tuned tomorrow for <a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-3-payer-8668f5fbb6e1">Part 3: B2B Payers</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4c08e5f0e047" width="1" height="1" alt=""><hr><p><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-2-providers-4c08e5f0e047">Show Me the Money: How To Get Paid In Healthcare (Part 2 — Providers)</a> was originally published in <a href="https://medium.com/outlier-ventures">Outlier Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Show Me the Money: How To Get Paid In Healthcare (Part 1)]]></title>
            <link>https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-1-805d66fb004f?source=rss-f71d3dd194e------2</link>
            <guid isPermaLink="false">https://medium.com/p/805d66fb004f</guid>
            <category><![CDATA[monetization-model]]></category>
            <category><![CDATA[who-pays]]></category>
            <category><![CDATA[healthcare-innovations]]></category>
            <category><![CDATA[biohackers]]></category>
            <dc:creator><![CDATA[Lusi Chien]]></dc:creator>
            <pubDate>Wed, 17 Mar 2021 18:42:49 GMT</pubDate>
            <atom:updated>2021-03-20T01:05:15.061Z</atom:updated>
            <content:encoded><![CDATA[<h3>Show Me the Money: How To Get Paid In Healthcare (Part 1 — Consumer)</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/609/0*GATpvYEKxJ7oC8lk.jpg" /><figcaption>A phrase from one of my favorite movies: Jerry Maguire, “Show me the money”</figcaption></figure><h3>Healthcare is one of the only industries where the consumer of the product / service is usually not the one who pays for it. Understanding who pays for healthcare is important in bringing innovation to the space that’s lasting.</h3><p>In my advising and consulting with early stage start-ups, I realized that while this might seem obvious to people who have been in healthcare for a while, for many tech entrepreneurs who are motivated to enter healthcare for the first time, this 101 knowledge is helpful in thinking about how to commercialize their new technology or service. When I say “healthcare” in this case, I am excluding pharma / biotech for the purposes of this article.</p><p>In a nutshell, healthcare services and medical devices are sold to these three major categories:</p><ol><li>B2C: the consumer (the smallest)</li><li><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-2-providers-4c08e5f0e047">B2B: the provider</a></li><li><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-3-payer-8668f5fbb6e1">B2B: the payer</a></li></ol><p>There are also business models that sell to medical device companies, but ultimately this is really a corollary to the above 3 to enable them to sell their products better and gain more market share.</p><p>This is a 4 part series where I dig into one of these daily</p><h3>B2C: The Consumer</h3><p><strong>What they care about</strong>: consumers want to take charge of their health because ultimately, they are the ones that are affected most by it. However, one of the reasons why innovation in healthcare is slower is due to the fact that consumers don’t always decide, know, or pay for the care / services they receive.</p><ul><li>Most consumers have insurance that pay for but also limit their options on the drugs or services they receive. This breeds a reluctance to pay for things that are not covered as costs for healthcare services can be significant.</li><li>Consumers do not have either the knowledge or information to decide their care (e.g. where you go for an outpatient MRI exam is largely dictated by where your doctor sends you, very few people actually search for “where to get an MRI exam” nor know what matters — 1.5T vs 3T scanner? who’s reading the scan? You could get scanned on the same scanner and have your scans read by the same radiologist but your bill at a hospital could be 3x that of a bill from an outpatient center down the street)</li><li>Finally the slice of information readily accessible to the consumer is not always the complete picture (e.g. data from your Apple Watch), as it need to be combined with what’s in your medical records as well as physician knowledge and opinions to interpret and direct action.</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*LPUZF6DF0Vj-OZWU" /></figure><p><strong>Typical profile: </strong>Most products that succeed in a B2C space typically target the “worried well” or “bio-hackers” — they tend to have more disposable income, care about their health, are willing to experiment, and want a effort / reward ratio that’s worth it (e.g. how much effort it takes me to track vs. what useful information do I get to change my life). Sometimes wearing these products can be a status symbol (e.g. Apple Watch, Oura Ring) as much as it is a helpful intervention. People like to advertise things like how much they’re running but less likely that they’re struggling with disease or other things that tend to be more private.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*diGDLNnUFFrvl_oJ" /><figcaption>Picture compliments of Oura Ring Website</figcaption></figure><p><strong>Example companies:</strong></p><ul><li><a href="https://www.apple.com/watch/">Apple Watch</a></li><li><a href="https://www.fitbit.com/global/us/home">Fitbit</a> — step tracking</li><li><a href="https://www.levelshealth.com/blog">Levels </a>— patch on your arm to tracks your glucose levels continuously and gives you feedback (1 month membership)</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*Qo-_DF11F6lleTvS.jpg" /><figcaption>Picture compliments of Levels website, notes with complimentary lifestyle brands such as Lululemon</figcaption></figure><ul><li><a href="https://ouraring.com/blog/">Oura </a>Ring — ring on your finger that tracks your sleep</li><li><a href="https://www.whoop.com/">Whoop </a>— fitness tracking band</li></ul><figure><img alt="Man in Whoop apparel — advertising the status symbol associated with owning a Whoop band" src="https://cdn-images-1.medium.com/max/800/0*VmoK7fuFX4Ab0OMm" /><figcaption>Man in Whoop apparel, further promoting the status symbol of owning a Whoop band</figcaption></figure><ul><li><a href="https://www.23andme.com/?sub=ver2&amp;cabt=nao">23andme </a>— genomic testing</li></ul><p><strong>Limitations: </strong>Given the target, this is typically not a mass market opportunity. Prices either reflect the segment — relatively wealthy, or a more one time purchase (e.g. fertility related items for a specific season). Given the limited, siloed feedback, it cannot affect the entirety of your health, though of course tracking some of these and impacting a healthier lifestyle will affect long term, chronic diseases and outcomes.</p><p><strong>Opportunity: </strong>While today this market is limited, there is huge potential as we move toward precision medicine and the combination of everyday tracking with medical data that could affect in particular chronic care which mostly takes place at home. The goal is to go from <strong>patient monitoring =&gt; prediction =&gt; prevention</strong>, and the more data points we have in aggregate, the better we are able to meet this goal given the bulk of the time spent is outside of the hospital. B2C could be a window into unlocking B2B revenue as well as provide more patient value by allowing for more data points to be combined with together for a holistic picture of the patient inside and outside of the hospital.</p><p>While I have excluded pharma in this overall article, I do want to mention here companies who have leveraged B2C to obtain specific and useful data that have unlocked stepwise value into pharma (e.g. <a href="https://www.23andme.com/?sub=ver2&amp;cabt=nao">23andme</a>)</p><p>Tomorrow I will dive into <a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-2-providers-4c08e5f0e047">B2B: Providers</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=805d66fb004f" width="1" height="1" alt=""><hr><p><a href="https://medium.com/outlier-ventures/show-me-the-money-how-to-get-paid-in-healthcare-part-1-805d66fb004f">Show Me the Money: How To Get Paid In Healthcare (Part 1)</a> was originally published in <a href="https://medium.com/outlier-ventures">Outlier Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Sales Deck 2.0: Shorten your B2B sale cycle by months]]></title>
            <link>https://medium.com/outlier-ventures/sales-deck-2-0-shorten-your-b2b-sale-cycle-by-months-525d21959b69?source=rss-f71d3dd194e------2</link>
            <guid isPermaLink="false">https://medium.com/p/525d21959b69</guid>
            <category><![CDATA[shorten-sales-cycle]]></category>
            <category><![CDATA[sales-deck]]></category>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[sales]]></category>
            <category><![CDATA[sales-cycle]]></category>
            <dc:creator><![CDATA[Lusi Chien]]></dc:creator>
            <pubDate>Wed, 03 Mar 2021 06:22:50 GMT</pubDate>
            <atom:updated>2021-03-03T06:22:50.648Z</atom:updated>
            <content:encoded><![CDATA[<h3>Evolve from selling your team to selling your product</h3><figure><img alt="" src="https://cdn-images-1.medium.com/max/840/0*paJAFZj8odZbuWyj.jpg" /></figure><p>I worked with and have been a part of many start-ups, and have seen many sales decks used for B2B sales, particularly in a healthcare setting.</p><p>Version 1.0 of the sales deck typically looks pretty much like an investor deck, it talks about your team, has logos of where they went to school and worked, it talks about your technology, but more about why / how it’s proprietary rather than the results to date.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*QBUv72qeX5e50X7X.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/307/0*THpET-Miwph2WNhC" /></figure><p>It may have some market size information or a general statement of the problem and solutions, such as better patient experience or more efficient operations. It may do an analysis of the total cost to the system — such as re-admissions, or errors in analysis, in large numbers published by articles (e.g. x% readmissions rate or y million people suffer from mental illness costing the system $Z).</p><p>Some products may be more revolutionary — such as a new way to collaborate or visualize, utilization new technologies such as AR / VR to re-imagine what’s possible, a new way to do primary care, a better health insurance, etc. and appeals to the user experience rather than a hard revenue lift or cost savings.</p><p>This 1.0 deck is needed, because your early adopters are going to be people who believe in your vision, see the same problem that you see, and are invested in your team. <strong>In some ways, they are more like your investors than they are your customers.</strong> The early adopters may or may not give you any revenue, but they help you gather data, publications, clinical evidence, testimonials, and experience operationalizing whatever it is that you are selling. Of course the goal is to be able to quantify your value to them at the end of a pilot or trial, so that you can use that case study, publication, etc. to 1. get them to renew and adopt more widely within the organization and 2. publish those results to others.</p><p>However, after your first 3–5 deals, or perhaps more if your deals are very varied, when you’ve identified your key customer personas, sales process, hear the same set of questions being asked, your sales deck needs a 2.0 revision.</p><p>Here’s what should change</p><ul><li><strong>Your credibility should come from your customers, </strong>and no longer your team (reserve the former for your investor deck, show where you’re published and deployed at instead)</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/930/0*F51bRsFRVS80qXr3" /></figure><ul><li><strong>It’s time to SHOW instead of TELL.</strong> Show how exactly your product works in as much detail as possible, paint a picture of a typical patient, clinician, or other end user. Instead of talking about how you reduce variability in outcomes, SHOW the dashboard, scan image, workflow, notification, and actions taken for Jane Doe, 73 year old patient with heart failure. What popped up for the nurse, the surgeon, and anyone else that touches the patient?</li><li><strong>Detailed results from one specific site </strong>will be more credible than industry wide savings or changes (show reductions in re-admission at the site you worked with, rather than industry wide ones, share testimonials from your clinical champions and other users — patients, nurses, technologists?)</li><li><strong>Reflect on the top 3 questions asked by your customers and create slides specifically addressing those</strong> (for example, is it about use cases? how you compare with competitors, or what the IT process looks like to set-up? Pre-empting their questions will help you not only prove your credibility, but also shorten the sale.)</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/760/0*jYjJQXkRehynKbuz.jpg" /></figure><ul><li><strong>Have specific next steps in templates</strong> — send IT set-up information, gather information such as the number of MRI scanners they have, (ideally some pre-filled from the call you just had), put forward a quote, etc. You direct the next steps conversation, don’t leave it open to “we’ll talk about it.”</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/310/1*AD5VrCdjKJuSUrgfHc7cBQ.png" /></figure><p>If done effectively, your sales deck 2.0 should shorten your sell cycle by answering questions that are typically asked in the next step, and the follow-up materials should automate the process (give them the information they need to create a business case, help them convince another stakeholder — such as IT to OK the deal, allow them to share information with them team effectively).</p><p>Do you have any experiences of how these steps helped your move or shorten a deal? I would love to hear from you.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=525d21959b69" width="1" height="1" alt=""><hr><p><a href="https://medium.com/outlier-ventures/sales-deck-2-0-shorten-your-b2b-sale-cycle-by-months-525d21959b69">Sales Deck 2.0: Shorten your B2B sale cycle by months</a> was originally published in <a href="https://medium.com/outlier-ventures">Outlier Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>